Figure 3
From: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
(a) Example Chromatogram (antisense strand) wild-type KRAS in a negative control sample. (b) Example Chromatogram (antisense strand) KRAS c.35G > A (pG12D) in a CTC sample. (c) Example ddPCR result (Patient 45) for KRAS G12D. The number of events is very low which represents a very low copy of mutant KRAS G12D molecules in the specimen. The circle encircles the area of interest and the approximately 6 events.
